Thymic carcinoma epidemiology: Difference between revisions
No edit summary |
Marjan Khan (talk | contribs) |
||
| (12 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}}; {{AE}} {{ | {{CMG}}; {{AE}}, {{Marjan}} | ||
==Overview== | ==Overview== | ||
The prevalence of thymic carcinoma is approximately 0.00006 per 100,000 individuals worldwide. Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1. It is more common in Asians and African Americans than in Caucasians. | The prevalence of thymic carcinoma is approximately 0.00006 per 100,000 individuals worldwide. Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1. It is more common in Asians and African Americans than in Caucasians. Thymic malignancies are relatively rare in the range of 0.2% to 1.5% of all malignancies or 0.13 per 100,000 person-years in the United States. Thymic malignancies are among the most common mediastinal primary tumors with up to 50% of anterior mediastinal masses proving to be of thymic descent. Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies. Thymic carcinoma are rare and have been reported to account for only 0.06% of all thymic neoplasms. The risk of thymic carcinoma increases with age. Thymic carcinoma is uncommon in children, it is seen more often in middle-aged adults. Thymic carcinoma commonly affects individuals between 40-60 years of age. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
*Thymic malignancies are relatively rare in the range of 0.2% to 1.5% of all malignancies or 0.13 per 100,000 person-years in the United States | |||
*Thymic malignancies are among the most common mediastinal primary tumors with up to 50% of anterior mediastinal masses proving to be of thymic descent. | |||
*Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies.<ref name=age>National Cancer Institute. General Information About Thymoma and Thymic Carcinoma Treatment. http://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq. Accessed on 22nd December, 2015.</ref> | *Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies.<ref name=age>National Cancer Institute. General Information About Thymoma and Thymic Carcinoma Treatment. http://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq. Accessed on 22nd December, 2015.</ref> | ||
*Thymic carcinoma are rare and have been reported to account for only 0.06% of all thymic neoplasms. | *Thymic carcinoma are rare and have been reported to account for only 0.06% of all thymic neoplasms. | ||
| Line 16: | Line 18: | ||
===Gender=== | ===Gender=== | ||
Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1. | *Males have a slightly higher risk of developing thymic malignancies than females, and the risk rises with age, reaching a peak in the seventh decade of life, which is in direct contrast to the progressive involution of the thymus with age. | ||
*Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1. | |||
===Race=== | ===Race=== | ||
It is more common in Asians and African Americans than in Caucasians. | *It is more common in Asians and African Americans than in Caucasians. | ||
==References== | ==References== | ||
| Line 25: | Line 28: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 23:06, 11 July 2019
|
Thymic Carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymic carcinoma epidemiology On the Web |
|
American Roentgen Ray Society Images of Thymic carcinoma epidemiology |
|
Risk calculators and risk factors for Thymic carcinoma epidemiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Marjan Khan M.B.B.S.[2]
Overview
The prevalence of thymic carcinoma is approximately 0.00006 per 100,000 individuals worldwide. Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1. It is more common in Asians and African Americans than in Caucasians. Thymic malignancies are relatively rare in the range of 0.2% to 1.5% of all malignancies or 0.13 per 100,000 person-years in the United States. Thymic malignancies are among the most common mediastinal primary tumors with up to 50% of anterior mediastinal masses proving to be of thymic descent. Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies. Thymic carcinoma are rare and have been reported to account for only 0.06% of all thymic neoplasms. The risk of thymic carcinoma increases with age. Thymic carcinoma is uncommon in children, it is seen more often in middle-aged adults. Thymic carcinoma commonly affects individuals between 40-60 years of age.
Epidemiology and Demographics
Prevalence
- Thymic malignancies are relatively rare in the range of 0.2% to 1.5% of all malignancies or 0.13 per 100,000 person-years in the United States
- Thymic malignancies are among the most common mediastinal primary tumors with up to 50% of anterior mediastinal masses proving to be of thymic descent.
- Invasive thymomas and thymic carcinomas are relatively rare tumors, which together represent about 0.2% to 1.5% of all malignancies.[1]
- Thymic carcinoma are rare and have been reported to account for only 0.06% of all thymic neoplasms.
Age
- The risk of thymic carcinoma increases with age.[1]
- Thymic carcinoma is uncommon in children, it is seen more often in middle-aged adults.
- Thymic carcinoma commonly affects individuals between 40-60 years of age.
Gender
- Males have a slightly higher risk of developing thymic malignancies than females, and the risk rises with age, reaching a peak in the seventh decade of life, which is in direct contrast to the progressive involution of the thymus with age.
- Males are more commonly affected with thymic carcinoma than females. The male to female ratio is approximately 3 to 1.
Race
- It is more common in Asians and African Americans than in Caucasians.
References
- ↑ 1.0 1.1 National Cancer Institute. General Information About Thymoma and Thymic Carcinoma Treatment. http://www.cancer.gov/types/thymoma/hp/thymoma-treatment-pdq. Accessed on 22nd December, 2015.